MGP Ingredients (NASDAQ:MGPI) Stock, Quote.Headers.trade-ideas

MGP Ingredients

MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives most of its revenue from the Distillery Solutions segment.

Small,Tasting,Glasses,With,Aged,Scotch,Whisky,On,Old,Dark

Analyst Color

Cannabis

Price Target

Events

Analyst Ratings

MGPI

Wedbush Securities reaffirms confidence in MGP Ingredients (MGPI), with a Buy rating and $120 price target. Analyst Gerald Pascarelli has a strong track record and highlights MGP&#39;s strong financials and adaptability in a dynamic market.

MGP Ingredients On Verge Of Growth In Food, Spirits Markets

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACVA

AGRX

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

ATNI

BBLG

BELFA

BZFD

DOCN

DPRO

EAST

ETSY

EZFL

GBNH

GSHD

INDV

KTOS

LCID

LNTH

LRHC

LUNG

MATV

MNPR

MNTS

NOVA

NVAX

NVDA

OCUL

QTWO

RELY

RILY

RIVN

ROOT

RXRX

SMCI

SNPS

SNPX

TRUE

VERO

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Long Ideas

Pre-Market Outlook

COCO

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 5 Risk Off Stocks That Could Lead To Your Biggest Gains In Q1

MGP Ingredients Inc

Guidance

MGP Ingredients Sees FY24 Sales $742M-$756M Vs $755.868M Est.; Adj. EPS $6.12-$6.23 Vs $6.17 Est.

MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) reported quarterly earnings of $1.71 per share which beat the analyst consensus estimate of $1.54 by 11.04 percent. The company reported quarterly sales of $190.805 million which beat the analyst consensus estimate of $189.056 million by 0.93 percent. This is a 8.71 percent decrease over sales of $209.001 million the same period last year.

Earnings

Earnings Beats

MGP Ingredients Q2 2024 Adj. EPS $1.71 Beats $1.54 Estimate, Sales $190.805M Beat $189.056M Estimate

Roth MKM analyst Sean McGowan maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and maintains $92 price target.

Roth MKM Maintains Buy on MGP Ingredients, Maintains $92 Price Target

Roth MKM analyst Sean McGowan maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $95 to $92.

Roth MKM Maintains Buy on MGP Ingredients, Lowers Price Target to $92

MGP Ingredients Sees FY24 $742M - $756M Vs. $754.62M Est; Adj EPS Of $6.12 - $6.23 Vs. $6.16 Est.

MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $0.98 by 9.18 percent. This is a 23.02 percent decrease over earnings of $1.39 per share from the same period last year. The company reported quarterly sales of $170.56 million which missed the analyst consensus estimate of $173.23 million by 1.54 percent. This is a 15.15 percent decrease over sales of $201.01 million the same period last year.

Earnings Misses

MGP Ingredients Q1 Adj $1.07 Beats $0.98 Estimate, Sales $170.56M Miss $173.23M Estimate

Wedbush analyst Gerald Pascarelli reiterates MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Outperform and maintains $120 price target.

Reiteration

Wedbush Reiterates Outperform on MGP Ingredients, Maintains $120 Price Target

Roth MKM analyst Sean McGowan maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $100 to $95.

Roth MKM Maintains Buy on MGP Ingredients, Lowers Price Target to $95

In a recent analysis,&nbsp;Wedbush&nbsp;Securities&nbsp;reaffirmed its confidence in MGP Ingredients Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>), a leading supplier of premium distilled spirits and specialty wheat proteins and starches. 
Equity research analyst and upcoming&nbsp;<a href="https://www.benzinga.com/events/cannabis-conference/" target="_blank" rel="noreferrer noopener">Benzinga Cannabis Capital Conference</a>&nbsp;speaker&nbsp;Gerald Pascarelli reiterated a Buy rating on the stock, setting a price target of $120. 
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/26165732/2231044_CCCFloridaGIF_V2_031124-38.gif" alt="" class="wp-image-266375" style="width:546px;height:auto" /></figure>
<h1 class="wp-block-heading">Industry Standing And Future Prospects</h1>
MGP Ingredients has distinguished itself in the food and beverage market with its diversified offerings and strategic market positioning. The company&#8217;s latest earnings for the quarter ending Sept. 30 highlighted a revenue of $211.62 million and a net profit of $13.21 million, demonstrating growth from the previous year&#8217;s figures of $201.15 million in revenue and a net profit of $23.81 million. These financials reflect MGP Ingredient&#8217;s robust operational framework and adaptability in a dynamic market landscape.
The broader analyst consensus mirrored Pascarelli&#8217;s optimistic outlook, with a Strong Buy rating and an average price target of $106.44 for MGP Ingredients. This consensus was buoyed by positive sentiment from corporate insiders, who have increased their share purchases.
<h1 class="wp-block-heading">MGP Ingredients At A Glance</h1>
Founded in 1941 and headquartered in Atchison, Kansas, MGP Ingredients specializes in manufacturing and trading high-quality food, beverage and specialty wheat protein and starch food ingredients. The company operates through its Distillery Products and Ingredient Solutions segments, delivering value across various consumer markets. 
With nearly $75 million in investments and a legacy of pioneering transactions, MGP Ingredients is poised for continued success, leveraging innovative financing models to navigate the complexities of the market.
<h1 class="wp-block-heading">Analyst Expertise Underpins Bullish Stance</h1>
Pascarelli brings extensive experience to his evaluations. Before his time at Wedbush, Pascarelli honed his expertise at Cowen, Inc., covering the beverage industry and contributing to research on the cannabis sector since its emergence in 2016.&nbsp;
His insights into market trends and consumer behavior have positioned him as a respected voice in the industry. This is highlighted by a solid track record that boasts an average return of 14.9% and a success rate of 55.17%.
The&nbsp;<a href="https://www.benzinga.com/events/cannabis-conference/" target="_blank" rel="noreferrer noopener">Benzinga Cannabis Capital Conference</a>&nbsp;is returning to Florida in a new venue in Hollywood on April 16 and 17, 2024. The two-day event at&nbsp;<a href="https://www.benzinga.com/events/cannabis-conference/" target="_blank" rel="noreferrer noopener">The Diplomat Beach Resort</a>&nbsp;will be a chance for entrepreneurs, both large and small, to network, learn, and grow.
Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars — this conference is the go-to event of the year for the cannabis world.&nbsp;<a href="https://www.benzinga.com/events/cannabis-conference/" target="_blank" rel="noreferrer noopener">Get your tickets now on&nbsp;</a><a href="http://bzcannabis.com/" target="_blank" rel="noreferrer noopener">bzcannabis.com</a><a href="https://www.benzinga.com/events/cannabis-conference/" target="_blank" rel="noreferrer noopener">&nbsp;– Prices will increase very soon!</a>
Photo: Shutterstock

Shares of Etsy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etsy#NASDAQ">ETSY</a>) fell sharply during Thursday&rsquo;s session after the company reported <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37261895/4-etsy-analysts-stand-firm-on-ratings-post-q4-earnings-point-to-buyer-growth-fee-ex">mixed fourth-quarter financial results.</a>
Etsy reported quarterly earnings of 62 cents per share which missed the analyst consensus estimate of 78 cents. The company reported quarterly sales of $842.3 million, beating the analyst consensus estimate of $827.81 million. 
Etsy shares dipped 7.5% to $71.34 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>La Rosa Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lrhc#NASDAQ">LRHC</a>) shares jumped 160.7% to $3.6499 after the company said it has acquired a 100% interest in the Company&#39;s franchisee - La Rosa Realty Winter Garden LLC located in Winter Garden, Florida.</li>
<li>BuzzFeed, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bzfd#NASDAQ">BZFD</a>) jumped 91.4% to $0.4150 after the company revealed the sale of Complex Networks to NTWRK, a live-streaming video commerce platform. The deal, valued at $108.6 million, will also result in a 16% reduction in BuzzFeed&rsquo;s workforce.</li>
<li>Monopar Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnpr#NASDAQ">MNPR</a>) rose 80.7% to $1.03 after the company disclosed promising preclinical data for its MNPR-101 radiopharma program targeting advanced cancers.</li>
<li>Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>) shares gained 40.8% to $12.21 after posting better-than-expected fourth-quarter results.</li>
<li>Novavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) jumped 34.7% to $5.36. Novavax has reached a settlement related to the 2021 advance purchase agreement for Novavax&#39;s prototype Covid-19 vaccine (NVX-COV2373).</li>
<li>EZFill Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezfl#NASDAQ">EZFL</a>) rose 34.3% to $1.86. EzFill announced preliminary 2023 revenues of $23 million, up 54% year over year.</li>
<li>Mercurity Fintech Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mfh#NASDAQ">MFH</a>) jumped 30% to $2.93.</li>
<li>Mativ Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/matv#NYSE">MATV</a>) gained 27.6% to $15.00 following upbeat earnings.</li>
<li>Venus Concept Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vero#NASDAQ">VERO</a>) shares climbed 26.9% to $1.6242 after the company received CE Mark from DEKRA Certification B.V. to market Venus Versa Pro in Europe.</li>
<li>Outset Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/om#NASDAQ">OM</a>) gained 26% to $4.0680 following upbeat results.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) rose 22.2% to $9.19 after announcing a $325.0 million private placement.</li>
<li>Remitly Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rely#NASDAQ">RELY</a>) shares rose 19.5% to $21.13 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) gained 19.3% to $18.13. B. Riley&rsquo;s board issued a statement regarding internal review.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) jumped 19.2% to $875.07. Supermicro announced a proposed offering of $1.5 billion of convertible senior notes due 2029.</li>
<li>Bone Biologics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bblg#NASDAQ">BBLG</a>) gained 18.4% to $3.73.</li>
<li>Amylyx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amlx#NASDAQ">AMLX</a>) rose 17.5% to $18.00 following strong sales results.</li>
<li>ACV Auctions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acva#NASDAQ">ACVA</a>) gained 16.9% to $16.37 after the company reported better-than-expected fourth-quarter financial results and announced the settlement of its antitrust litigation related to the AutoIMS technology platform.</li>
<li>FTI Consulting, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fcn#NYSE">FCN</a>) jumped 15.5% to $219.72 following upbeat results.</li>
<li>NVIDIA Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) rose 15.4% to $778.61 after the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for the first quarter.</li>
<li>OUTFRONT Media Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/out#NYSE">OUT</a>) gained 15.4% to $14.35 following upbeat results.</li>
<li>Lantheus Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lnth#NASDAQ">LNTH</a>) rose 14.4% to $64.90 following strong results.</li>
<li>Enerplus Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/erf#NYSE">ERF</a>) rose 13.7% to $18.67.</li>
<li>Indivior PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/indv#NASDAQ">INDV</a>) gained 13.3% to $19.83 following fourth-quarter results.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxrx#NASDAQ">RXRX</a>) rose 12.2% to $13.88.</li>
<li>Agile Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agrx#NASDAQ">AGRX</a>) gained 11.1% to $1.10. Agile Therapeutics was granted extension by Nasdaq Hearings Panel to regain compliance until March 25, 2024. The company sees FY23 revenue of $20 million to $21 million. Agile Therapeutics announces exercise of warrants for $4.8 million gross proceeds.</li>
<li>Synopsys, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snps#NASDAQ">SNPS</a>) gained 10.7% to $601.93 after the company reported better-than-expected first-quarter adjusted EPS results and issued strong guidance.</li>
<li>Q2 Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtwo#NASDAQ">QTWO</a>) rose 9.5% to $45.82 following strong results.</li>
<li>Eastside Distilling, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/east#NASDAQ">EAST</a>) shares rose 7.6% to $1.0340.</li>
<li>DigitalOcean Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/docn#NYSE">DOCN</a>) gained 6.8% to $38.29 following upbeat results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Draganfly Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dpro#NASDAQ">DPRO</a>) shares fell 50.3% to $0.1790 after the company announced pricing of $3.6 million underwritten public offering.</li>
<li>Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) fell 46.6% to $0.2024 after the company announced a $1.2 million registered direct offering of 6 million shares at $0.20 per share purchase price.</li>
<li>Synaptogenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpx#NASDAQ">SNPX</a>) shares fell 29.5% to $0.1839 after surging 29% on Wednesday. Synaptogenix received a Notice of Allowance for its U.S. Patent application 17/665,033 titled &quot;Halogenated Esters of Cyclopropanated Unsaturated Fatty Acids for Use in the Treatment of Neurodegenerative Diseases.&quot;</li>
<li>Rivian Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rivn#NASDAQ">RIVN</a>) fell 26.8% to $11.25 after the company reported a wider-than-expected loss for its fourth quarter and announced plans to reduce its salaried workforce by around 10% to help further improve costs. The company said it sees production of 57,000 vehicles in 2024.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) fell 23.2% to $1.0750.</li>
<li>Goosehead Insurance, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gshd#NASDAQ">GSHD</a>) dipped 21.2% to $68.78 after the company reported worse-than-expected fourth-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Bel Fuse Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/belfa#NASDAQ">BELFA</a>) fell 20.1% to $59.16 after the company reported weak fourth-quarter financial results.</li>
<li>Lucid Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcid#NASDAQ">LCID</a>) shares fell 19.1% to $2.9912 after the company reported mixed fourth-quarter financial results and issued guidance.</li>
<li>Sunnova Energy International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) dipped 18.6% to $9.52 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>ATN International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atni#NASDAQ">ATNI</a>) declined 18.1% to $29.20 after the company reported fourth-quarter financial results and issued guidance.</li>
<li>Pulmonx Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lung#NASDAQ">LUNG</a>) fell 17.6% to $11.94 after the company reported fourth-quarter financial results.</li>
<li>MGP Ingredients, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgpi#NASDAQ">MGPI</a>) declined 14.3% to $78.75 after the company reported fourth-quarter financial results.</li>
<li>Momentus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnts#NASDAQ">MNTS</a>) shares fell 13.1% to $0.5995 after declining around 7% on Wednesday.</li>
<li>Standard Motor Products, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smp#NYSE">SMP</a>) dipped 12.7% to $35.01 after the company reported worse-than-expected fourth-quarter financial results and issued guidance.</li>
<li>Teekay Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tk#NYSE">TK</a>) gained 12.4% to $7.21 after the company reported a year-over-year decrease in Q4 financial results.</li>
<li>TrueCar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/true#NASDAQ">TRUE</a>) dipped 11% to $3.4450 following weak sales.</li>
<li>Kratos Defense &amp; Security Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktos#NASDAQ">KTOS</a>) fell 8% to $18.57. Kratos Defense &amp; Security Solutions announced a proposed public offering of $300 million of common stock.</li>
<li>Rogers Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rog#NYSE">ROG</a>) fell 6.8% to $108.29 following weak quarterly results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/02/37262506/booking-holdings-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earni"> Booking Holdings Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call </a>

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

WIIM

MGP Ingredients shares are trading lower after the company reported Q4 financial results.

MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) reported quarterly earnings of $1.64 per share which beat the analyst consensus estimate of $1.36 by 20.59 percent. This is a 62.38 percent increase over earnings of $1.01 per share from the same period last year. The company reported quarterly sales of $214.89 million which beat the analyst consensus estimate of $205.39 million by 4.62 percent. This is a 12.51 percent increase over sales of $191.00 million the same period last year.

MGP Ingredients Q4 Adj. EPS $1.64 Beats $1.36 Estimate, Sales $214.89M Beat $205.39M Estimate

KYMR

LASR

LAUR

LILA

MAIN

MELI

MITT

MODV

MORN

MRIN

MRNA

MRVI

NABL

NICE

NMRK

NTLA

NURO

NVCR

NVEE

OLED

ONTF

OPCH

PKST

PLNT

PLYA

PODD

POOL

PRMW

RCEL

RLAY

RMAX

RYTM

SHYF

SMSI

SNBR

SPXC

STWD

TALK

TECK

THRY

TPIC

UPBD

UPLD

VALE

VCYT

VICI

VICR

WTRG

XPEL

ZEUS

Earnings Scheduled For February 22, 2024

Wedbush analyst Gerald Pascarelli reiterates MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Outperform and maintains $135 price target.

Wedbush Reiterates Outperform on MGP Ingredients, Maintains $135 Price Target

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>The Vita Coco Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coco#NASDAQ">COCO</a>)</h3>
<ul>
<li>On Jan. 31, Goldman Sachs analyst Bonnie Herzog maintained Vita Coco with a Buy and lowered the price target from $32 to $28. The company&rsquo;s stock fell around 21% over the past month and has a <a href="https://www.benzinga.com/quote/COCO">52-week low of $13.40 </a>.</li>
<li>RSI Value: 25.44</li>
<li>COCO Price Action: Shares of Vita Coco fell 1.7% to close at $19.61 on Monday.</li>
</ul>
<h3>MGP Ingredients, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgpi#NASDAQ">MGPI</a>)</h3>
<ul>
<li>On Jan. 8, MGP Ingredients announced the promotion of Amel Pasagic to the newly created position of Chief Commercial Officer. &ldquo;Amel&rsquo;s wealth of experience and his unique strategic view of our business will be critical in driving the next phase of growth for MGP,&rdquo; said David Bratcher, MGP President and Chief Executive Officer. &ldquo;We are fortunate to have Amel assume this new role and look forward to his leadership as we continue to leverage the solid foundation we have established and seize the significant opportunities that remain ahead of us.&rdquo; The company&rsquo;s stock fell around 8% over the past five days. It <a href="https://www.benzinga.com/quote/MGPI"> has a 52-week low </a> of $81.11.</li>
<li>RSI Value: 29.40</li>
<li>MGPI Price Action: Shares of MGP Ingredients fell 3% to close at $81.64 on Monday.</li>
</ul>
<h3>Fresh Del Monte Produce Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fdp#NYSE">FDP</a>)</h3>
<ul>
<li>On Nov. 1, Fresh Del Monte Produce reported worse-than-expected third-quarter results. The company&rsquo;s stock fell around 12% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/FDP"> low of $21.41.</a></li>
<li>RSI Value: 29.26</li>
<li>FDP Price Action: Shares of Fresh Del Monte Produce fell 3% to close at $23.79 on Monday.</li>
</ul>
<h3>Grocery Outlet Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/go#NASDAQ">GO</a>)</h3>
<ul>
<li>On Jan. 25, Grocery Outlet announced that it has appointed Ramesh Chikkala to the newly created position of EVP, Chief Operations Officer. &quot;Ramesh is an ideal fit for this new position with his extensive leadership and operating experience in both supply chain and technology,&quot; said RJ Sheedy, President and Chief Executive Officer. &quot;He has deep expertise in end-to-end supply chain transformation and business digitalization. This position represents continued investment in our business operations, which is critical to delivering our value proposition and supporting future revenue and profit growth.&quot; The company&rsquo;s shares lost around 9% over the past month. The company&rsquo;s 52-week low is $23.88.</li>
<li>RSI Value: 25.20</li>
<li>GO Price Action: Shares of Grocery Outlet fell 3.2% to close at $23.90 on Monday.</li>
</ul>
<h3>Archer-Daniels-Midland Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adm#NYSE">ADM</a>)</h3>
<ul>
<li>According to a leaked memo, Archer-Daniels-Midland has decided to postpone the payment of performance bonuses to some of its executives. The decision comes in the wake of an ongoing investigation into the company&rsquo;s accounting practices. The company&rsquo;s shares fell around 25% over the past month. The company <a href="https://www.benzinga.com/quote/ADM"> has a 52-week low </a> of $50.72.</li>
<li>RSI Value: 27.98</li>
<li>ADM Price Action: Shares of Archer-Daniels-Midland fell 4.9% to close at $52.96 on Monday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/24/02/36947853/investor-sentiment-improves-following-services-pmi-s-p-500-slips-from-record-levels"> Investor Sentiment Improves Following Services PMI; S&amp;P 500 Slips From Record Levels </a>

Management

MGP Ingredients Disclosed the Retirement Of David Colo From The Role Of Chief Executive Officer And President, Effective December 31, And Appointment Of David Bratcher As The Replacement Effective January 1, 2024

MGP Ingredients Expects FY23 Adj EPS Of $5.50 - $5.65 Vs. $5.41 Est.

MGP Ingredients Sees FY23 Revenue Of $815M - $835M Vs. $827.19M Est.

MGP Ingredients declares $0.12 dividend

TD Cowen analyst Robert Moskow has maintained their bullish stance on MGPI stock, giving a Buy rating today. Robert Moskow has given his Buy rating...

MGP Ingredients Earns 'Buy' Rating on Strong Q2 Performance and Positive Market Positioning

In a report released today, Bill Chappell from Truist Financial maintained a Buy rating on MGP Ingredients (MGPI – Research Report). The company's ...

Truist Financial Sticks to Their Buy Rating for MGP Ingredients (MGPI)

Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on UTZ Brands (UTZ – Research Report) and MGP Ing...

Analysts Offer Insights on Consumer Goods Companies: UTZ Brands (UTZ) and MGP Ingredients (MGPI)

Roth MKM analyst Sean McGowan maintained a Buy rating on MGP Ingredients (MGPI – Research Report) today and set a price target of $92.00. The compa...

MGP Ingredients (MGPI) Gets a Buy from Roth MKM

MGP Ingredients, Inc (MGPI) Q2 2024 Earnings Call Transcript

Intrinsic Valuation Of MGP Ingredients Reveals It's Overvalued

Stock Picks From Seeking Alpha's August 2024 New Analysts

Guggenheim SMid Cap Value Fund Q2 2024 Commentary

MGP Ingredients ( ($MGPI) ) has issued an update. MGP Ingredients, Inc.'s Board of Directors has approved immediate amendments to the company's byl...

MGP Ingredients Modernizes Governance with Bylaw Amendments

ABNB

AMKR

BRBOF

BRBOY

BTSG

BTSGU

CHGG

CLPR

COHR

ENOV

EVRG

FANG

FLTLF

FRCOF

FRCOY

INTC

IREN

LDOS

LULU

MANH

MMDCF

MNMD

NIOIF

REPYF

REPYY

ROAD

RTMVF

RTMVY

SWGAF

SWGAY

SWGNF

TSX:AUM

VEOEF

VEOEY

VGSH

Press Releases

Ross & Squibb Distillery enhances barrel program for 2024 with custom selection kits and guided in-person and virtual tasting options

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

MGP Ingredients

MGP Ingredients (MGPI) Forecast

MGP Ingredients (NASDAQ:MGPI) Stock, Quote.Headers.trade-ideas